O2h Ventures — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Five Alarm Bio develops pharmaceutical compounds targeting a novel aging mechanism to prevent and treat age-related chronic diseases.
BiotechLongevity
William Bains(Founding scientist)in
Co-investorsCambridge Angels groupSyndicateRoom
PharmEnable applies AI to small molecule drug discovery, focusing on challenging and data-sparse biological targets that traditional methods struggle to address.
AI & Machine LearningBiotechDeep Tech
Hannah Sore(Founder)in
Co-investorsCambridge Angels groupMartlet CapitalMC Healthcare VenturesParkwalk AdvisorsWren Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.